Lung volumes predict survival in patients with chronic lung allograft dysfunction

被引:35
作者
Kneidinger, Nikolaus [1 ]
Milger, Katrin [1 ]
Janitza, Silke [2 ]
Ceelen, Felix [1 ]
Leuschner, Gabriela [1 ]
Dinkel, Julien [3 ]
Koenigshoff, Melanie [4 ]
Weig, Thomas [5 ]
Schramm, Rene [6 ]
Winter, Hauke [7 ]
Behr, Juergen [1 ]
Neurohr, Claus [1 ]
机构
[1] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Dept Internal Med 5, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Med Informat Biometry & Epidemiol, Munich, Germany
[3] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Inst Clin Radiol, Munich, Germany
[4] German Ctr Lung Res DZL, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr CPC M, Res Unit Lung Repair & Regenerat, Munich, Germany
[5] Univ Munich, Dept Anaesthesiol, Munich, Germany
[6] Univ Munich, Clin Cardiac Surg, Munich, Germany
[7] Univ Munich, Dept Thorac Surg, Munich, Germany
关键词
BRONCHIOLITIS OBLITERANS SYNDROME; THIN-SECTION CT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; TRANSPLANTATION; HYPERINFLATION; MORTALITY; ONSET;
D O I
10.1183/13993003.01315-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Identification of disease phenotypes might improve the understanding of patients with chronic lung allograft dysfunction (CLAD). The aim of the study was to assess the impact of pulmonary restriction and air trapping by lung volume measurements at the onset of CLAD. A total of 396 bilateral lung transplant recipients were analysed. At onset, CLAD was further categorised based on plethysmography. A restrictive CLAD (R-CLAD) was defined as a loss of total lung capacity from baseline. CLAD with air trapping (AT-CLAD) was defined as an increased ratio of residual volume to total lung capacity. Outcome was survival after CLAD onset. Patients with insufficient clinical information were excluded (n=95). Of 301 lung transplant recipients, 94 (31.2%) developed CLAD. Patients with R-CLAD (n=20) and AT-CLAD (n=21), respectively, had a significantly worse survival (p<0.001) than patients with non-R/AT-CLAD. Both R-CLAD and AT-CLAD were associated with increased mortality when controlling for multiple confounding variables (hazard ratio (HR) 3.57, 95% CI 1.39-9.18; p=0.008; and HR 2.65, 95% CI 1.05-6.68; p=0.039). Furthermore, measurement of lung volumes was useful to identify patients with combined phenotypes. Measurement of lung volumes in the long-term follow-up of lung transplant recipients allows the identification of patients who are at risk for worse outcome and warrant special consideration.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction
    Leuschner, Gabriela
    Lauseker, Michael
    Howanietz, Anne-Sophie
    Milger, Katrin
    Veit, Tobias
    Munker, Dieter
    Schneider, Christian
    Weig, Thomas
    Michel, Sebastian
    Barton, Juergen
    Meiser, Bruno
    Dinkel, Julien
    Neurohr, Claus
    Behr, Juergen
    Kneidinger, Nikolaus
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (11) : 1270 - 1278
  • [32] Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle
    Gardiner, Bradley J.
    Snydman, David R.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (03) : 320 - 322
  • [33] Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation
    Iturbe-Fernandez, David
    Gafas, Alicia de Pablo
    Cuesta, Victor Manuel Mora
    Moralejo, Rodrigo Alonso
    Loaiza, Carlos Andres Quezada
    Perez Gonzalez, Virginia
    Lopez-Padilla, Daniel
    Cifrian, Jose M.
    LIFE-BASEL, 2024, 14 (05):
  • [34] Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation
    Shino, M. Y.
    Weigt, S. S.
    Li, N.
    Derhovanessian, A.
    Sayah, D. M.
    Huynh, R. H.
    Saggar, R.
    Gregson, A. L.
    Ardehali, A.
    Ross, D. J.
    Lynch, J. P., III
    Elashoff, R. M.
    Belperio, J. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (05) : 1294 - 1303
  • [35] Montelukast in chronic lung allograft dysfunction after lung transplantation
    Vos, Robin
    Vanden Eynde, Ruben
    Ruttens, David
    Verleden, Stijn E.
    Vanaudenaerde, Bart M.
    Dupont, Lieven J.
    Yserbyt, Jonas
    Verbeken, Eric K.
    Neyrinck, Arne P.
    Van Raemdonck, Dirk E.
    Verleden, Geert M.
    Godinas, Laurent
    Van Herck, Anke
    Vanstapel, Arno
    Sacreas, Annelore
    Kaes, Janne
    Heigl, Tobias
    Ordies, Sofie
    Schaevers, Veronique
    De Leyn, Paul
    Coosemans, Willy
    Nafteux, Philippe
    Decaluwe, Herbert
    Van Veer, Hans
    Depypere, Lieven
    Frick, Anna E.
    Ceulemans, Laurens J.
    Weynand, Birgit
    Emonds, Marie-Paule
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (05) : 516 - 527
  • [36] Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation
    Evans, Rickey A.
    Walter, Krysta S.
    Lobo, Leonard Jason
    Coakley, Raymond
    Doligalski, Christina T.
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
  • [37] Impact of Forced Vital Capacity Loss on Survival after the Onset of Chronic Lung Allograft Dysfunction
    Todd, Jamie L.
    Jain, Rahil
    Pavlisko, Elizabeth N.
    Copeland, C. Ashley Finlen
    Reynolds, John M.
    Snyder, Laurie D.
    Palmer, Scott M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (02) : 159 - 166
  • [38] Chronic lung allograft dysfunction phenotypes and treatment
    Verleden, Stijn E.
    Vos, Robin
    Vanaudenaerde, Bart M.
    Verleden, Geert M.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2650 - 2659
  • [39] Infectious Triggers of Chronic Lung Allograft Dysfunction
    Gregson, Aric L.
    CURRENT INFECTIOUS DISEASE REPORTS, 2016, 18 (07)
  • [40] The Role of Galectins in Chronic Lung Allograft Dysfunction
    D'Alessandro, Miriana
    Bergantini, Laura
    Fossi, Antonella
    De Vita, Elda
    Perillo, Felice
    Luzzi, Luca
    Paladini, Piero
    Sestini, Piersante
    Rottoli, Paola
    Bargagli, Elena
    Bennett, David
    LUNG, 2021, 199 (03) : 281 - 288